These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3164609)
1. Prevention of 1-beta-D arabinofuranosylcytosine toxicity by 4-nitrobenzyl-6-thioinosine or dipyridamole in human leukemia cell lines. Kubota M; Takimoto T; Kitoh T; Tanizawa A; Kiriyama Y; Akiyama Y; Mikawa H Anticancer Res; 1988; 8(3):339-42. PubMed ID: 3164609 [TBL] [Abstract][Full Text] [Related]
2. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx. Prus KL; Averett DR; Zimmerman TP Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin). Cass CE; King KM; MontaƱo JT; Janowska-Wieczorek A Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux. Chan TC Cancer Res; 1989 May; 49(10):2656-60. PubMed ID: 2713849 [TBL] [Abstract][Full Text] [Related]
5. Selective protection of tubercidin toxicity by nitrobenzyl thioinosine in normal tissues but not in human neuroblastoma cells. Kaplinsky C; Yeger H; Estrov Z; Barankiewicz J; Pawlin G; Freedman MH; Cohen A Cancer Chemother Pharmacol; 1986; 17(3):264-8. PubMed ID: 3742712 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts. White JC; Hines LH; Rathmell JP Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845 [TBL] [Abstract][Full Text] [Related]
7. Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine. Higashigawa M; Ido M; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M; Taniguchi K; Hamazaki M Leuk Res; 1991; 15(4):255-62. PubMed ID: 2030607 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K; Nayak R; Grant S Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [TBL] [Abstract][Full Text] [Related]
9. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides. Dagnino L; Paterson AR Cancer Res; 1990 Oct; 50(20):6549-53. PubMed ID: 1698538 [TBL] [Abstract][Full Text] [Related]
10. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells. Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole. Yang JL; White JC; Capizzi RL Cancer Chemother Pharmacol; 1992; 29(3):236-40. PubMed ID: 1733557 [TBL] [Abstract][Full Text] [Related]
12. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Abe I; Saito S; Hori K; Suzuki M; Sato H Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60. Grant S; Bhalla K; Rauscher F; Cadman E Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943 [TBL] [Abstract][Full Text] [Related]
14. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs. Cole PD; Smith AK; Kamen BA Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974 [TBL] [Abstract][Full Text] [Related]
15. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability. Matsushita T; Ryu EK; Hong CI; MacCoss M Cancer Res; 1981 Jul; 41(7):2707-13. PubMed ID: 7248939 [TBL] [Abstract][Full Text] [Related]
16. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity. Tanaka M; Yoshida S Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells. Belt JA Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117 [TBL] [Abstract][Full Text] [Related]
18. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells. Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine. Plagemann PG; Kraupp M Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459 [TBL] [Abstract][Full Text] [Related]
20. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells. Plagemann PG; Wohlhueter RM Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]